Good news but nothing that will advance the share
Post# of 72440
Now if we get another PR this week that says a suitable amount of liquid (IV) Brilacidin to start testing on human patients by XXXX date will be available in BOTH Europe and USA, then that may be the catalyst to start some serious investment in IPIX by many. The need for investors to know that Brilacidin is available in bulk and specific as to when it becomes available and that it will IMMEDIATELY be in patient trials (would hope some date as to that is given) is the boots-hitting-the-dirt kind of PR we need to show events are well beyond the talking stage.
This PR sounds too much like just another "in discussions" statement.